SINGULAIR 5 MG PAED 28 TAB
11.520 د.ك
Singulair is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short-acting ß-agonists provide inadequate clinical control of asthma.
Related products
-
AERINAZE 2.5MG/120MG 14 TAB
1.870 د.ك -
AERIUS ORAL SOLUTION 0.5 MG 150 ML
1.930 د.ك -
AMYDRAMINE SYP 120 ML
0.780 د.ك -
ATROVENT 250 MCG/2 ML UNIT DOSE 20 VIAL
2.240 د.ك -
BRONCHO-VAXOM 3.5MG CHILDREN 30 CAP
6.500 د.ك
